Andrew B Smitherman
Overview
Explore the profile of Andrew B Smitherman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nichols H, Anderson C, Baggett C, Cannizzaro N, Engel S, Getahun D, et al.
Int J Cancer
. 2025 Feb;
PMID: 39991780
Lower birth rates and higher pregnancy loss are observed after childhood cancer. Studies specific to adolescent and young adult (AYA) cancer rarely have information on pregnancies that do not end...
2.
Ross W, Santiago-Rivera Y, Tan M, Roy M, Bryant S, Appel B, et al.
Contemp Clin Trials
. 2025 Feb;
152:107859.
PMID: 39987960
Background: Despite heightened risk of chronic health conditions, <20 % of childhood cancer survivors (CCS) receive guideline-recommended surveillance for late effects. Barriers include avoidance of reminders, lack of knowledge, and...
3.
Waters A, Warner E, Smitherman A, Swift C, Wilson J, Rosenstein D, et al.
J Adolesc Young Adult Oncol
. 2025 Jan;
PMID: 39761128
Young adult (YA) LGBTQ+ cancer survivors face inequities and unmet needs that impact their well-being. However, the impact of age and cancer among LGBTQ+ individuals have not been adequately assessed....
4.
Wilson S, Mitin N, Miller V, Smitherman A, Carden M
Aging (Albany NY)
. 2024 Nov;
16(21):13225-13236.
PMID: 39546497
People living with sickle cell disease (SCD) experience complications indicative of an accelerated aging phenotype typified by early decline in physical function and increased risk for age-related conditions. Cellular senescence,...
5.
Stein J, Wardell A, Ritzwoller D, Swift C, Matson M, Winslow H, et al.
JNCI Cancer Spectr
. 2024 Oct;
8(5).
PMID: 39400612
Cancer care organizations often struggle to adequately address the unique needs of adolescent and young adult cancer patients, resulting in poorer outcomes compared with other age groups. Creation of adolescent...
6.
Wernli K, Haupt E, Chawla N, Osuji T, Shen E, Smitherman A, et al.
J Adolesc Young Adult Oncol
. 2024 Apr;
13(5):738-747.
PMID: 38682323
Understanding emergency department (ED) use in adolescent and young adult (AYA) survivors could identify gaps in AYA survivorship. We conducted a cohort study of 7925 AYA survivors (aged 15-39 years...
7.
van Thiel Berghuijs K, Kaddas H, Warner E, Fair D, Fluchel M, Knackstedt E, et al.
BMC Health Serv Res
. 2023 Nov;
23(1):1215.
PMID: 37932718
Background: Vaccinations are a vital part of routine childhood and adolescent preventive care. We sought to identify current oncology provider practices, barriers, and attitudes towards vaccinating childhood and adolescent cancer...
8.
Coffman E, Smitherman A, Willis E, Ward D, Tate D, Valle C
J Cancer Surviv
. 2023 Aug;
19(1):54-65.
PMID: 37610479
Purpose: The physical frailty phenotype identifies individuals at risk for adverse health outcomes but has rarely been assessed among young adult cancer survivors (YACS). This study describes frailty status among...
9.
Coffman E, Smitherman A, Willis E, Ward D, Tate D, Valle C
Res Sq
. 2023 Jul;
PMID: 37461600
The physical frailty phenotype identifies individuals at risk for adverse health outcomes but has rarely been assessed among young adult cancer survivors (YACS). This study describes frailty status among YACS...
10.
Haines E, Lux L, Stein J, Swift C, Matson M, Childers J, et al.
J Adolesc Young Adult Oncol
. 2023 May;
12(6):868-878.
PMID: 37155196
Every year, nearly 100,000 adolescents and young adults (15-39 years, AYAs) are diagnosed with cancer in the United States and many have unmet physical, psychosocial, and practical needs during and...